Please enable Javascript
Samer Srour, MB
Samer Srour, MB, MD Anderson Cancer Center
Articles by Samer Srour, MB
Targeting CD70 With ALLO-316 in Advanced Clear Cell RCC: Updated Phase 1 Results From TRAVERSE
Samer Srour, MB
Advanced Renal Cell Carcinoma
|
June 30, 2025
Samer Srour, MB, talks about the updated ALLO-316 and its use in targeting CD70 in patients with advanced ccRCC.
View More